Condition
CIN - Cervical Intraepithelial Neoplasia
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting2
Completed1
Active Not Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06979180Not ApplicableRecruitingPrimary
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
NCT06942286Not ApplicableEnrolling By Invitation
Primary HPV Self-Collection in Indonesia
NCT06862102RecruitingPrimary
Multiple Human Papillomavirus Infections in the Development of CIN
NCT06776055Active Not Recruiting
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
NCT03697226Phase 1Completed
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Showing all 5 trials